Literature DB >> 23932500

Preformed albumin corona, a protective coating for nanoparticles based drug delivery system.

Qiang Peng1, Shu Zhang, Qin Yang, Ting Zhang, Xue-Qin Wei, Li Jiang, Chao-Liang Zhang, Qian-Ming Chen, Zhi-Rong Zhang, Yun-Feng Lin.   

Abstract

The non-specific interaction between nanoparticles (NPs) and plasma proteins occurs immediately after NPs enter the blood, resulting in the formation of the protein corona that thereafter replaces the original NPs and becomes what the organs and cells really see. Consequently, the in vivo fate of NPs and the biological responses to the NPs are changed. This is one substantial reason for the two main problems of the NPs based drug delivery system, i.e. nanotoxicity and rapid clearance of NPs from the blood after intravenous injection. Here, we demonstrate the successful application of the preformed albumin corona in inhibiting the plasma proteins adsorption and decreasing the complement activation, and ultimately in prolonging the blood circulation time and reducing the toxicity of the polymeric PHBHHx NPs. Since the interaction of proteins with various nano-materials and/or -particles is ubiquitous, pre-forming albumin corona has a great potential to be a versatile strategy for optimizing the NPs based drug delivery system.
© 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Albumin; Long circulation; Nanoparticles; Opsonization; Protein adsorption; Toxicity

Mesh:

Substances:

Year:  2013        PMID: 23932500     DOI: 10.1016/j.biomaterials.2013.07.102

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  69 in total

Review 1.  Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Authors:  Elena V Batrakova; Myung Soo Kim
Journal:  J Control Release       Date:  2015-08-01       Impact factor: 9.776

2.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

3.  Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.

Authors:  Joonyoung Park; Bo Sun; Yoon Yeo
Journal:  J Control Release       Date:  2016-12-31       Impact factor: 9.776

Review 4.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

5.  Allosteric effects of gold nanoparticles on human serum albumin.

Authors:  Qing Shao; Carol K Hall
Journal:  Nanoscale       Date:  2016-12-07       Impact factor: 7.790

Review 6.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

Review 7.  Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Authors:  Darren Michael Moss; Marco Siccardi
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 8.  Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma.

Authors:  Justin Hall; Shilpa Prabhakar; Leonora Balaj; Charles P Lai; Richard A Cerione; Xandra O Breakefield
Journal:  Cell Mol Neurobiol       Date:  2016-03-26       Impact factor: 5.046

9.  Nanosac, a Noncationic and Soft Polyphenol Nanocapsule, Enables Systemic Delivery of siRNA to Solid Tumors.

Authors:  Hyungjun Kim; Simseok A Yuk; Alexandra M Dieterly; Soonbum Kwon; Jinho Park; Fanfei Meng; Hytham H Gadalla; Maria Jose Cadena; L Tiffany Lyle; Yoon Yeo
Journal:  ACS Nano       Date:  2021-03-01       Impact factor: 15.881

Review 10.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.